YSP Southeast Asia confident in sustained growth for pharmaceutical products

KUALA LUMPUR: Y.S.P. Southeast Asia Holding Bhd (YSPAH) remains optimistic that the growth prospects of pharmaceutical products will continue.

The pharmaceutical company added that it will take cautious approaches in reviewing and monitoring market conditions to be in line with changing market trends.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Y.S.P. Southeast Asia , YSPAH , pharmaceutical

Next In Business News
Stocks wobble, dollar tips as Trump-Fed feud deepens
AIBIM appoints Rafe Haneef as president
Foreign investors turn net buyers with RM42.5mil equities inflow last week
Trading in Sunway, IJM shares suspended pending anouncement
FBM KLCI maintains rally as risk appetite improves
Trading ideas: Capital A, Iconic, UEM, MMAG, Meta Bright, KKB, Global Oriental, Reneuco, ITMAX, Insights Analytics
Ringgit opens marginally lower as US policy repricing lifts DXY
JPMorgan poised to profit from Maduro arrest
Malaysia can rest easy for now
MiniMax shares double in IPO debut

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.